Published in Psychopharmacology (Berl) on May 26, 2004
Defeating cancer with antidepressants. Ecancermedicalscience (2008) 0.75
Antidepressant medication use and breast cancer risk. Am J Epidemiol (2000) 2.29
Affective disorders and mortality. A general population study. Arch Gen Psychiatry (1987) 1.95
Response to "Antidepressants and cancer: cause for concern?". J Clin Psychopharmacol (1993) 1.95
Psychoneuroendocrine influences on immunocompetence and neoplasia. Science (1981) 1.88
Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun (2002) 1.52
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs (1997) 1.38
Mouse mammary tumors: alteration of incidence as apparent function of stress. Science (1975) 1.29
Stress-induced modulation of the immune response. Science (1977) 1.27
Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol (1990) 1.26
Psychological depression and 17-year risk of death from cancer. Psychosom Med (1981) 1.15
Neural-immune interactions in health and disease. Ann N Y Acad Sci (2002) 1.09
Benzodiazepines, anxiety and immunity. Pharmacol Ther (1997) 1.01
Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol (1999) 0.99
Antidepressant medications and risk for cancer. Epidemiology (2000) 0.95
Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB J (1996) 0.94
Neuroendocrine peptide hormones and their receptors in the immune system. Production, processing and action. J Neuroimmunol (1985) 0.93
Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. Eur J Pharmacol (1995) 0.85
Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res (1994) 0.83
Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol (1990) 0.83
Lowering of innate resistance of the lungs to the growth of blood-borne cancer cells in states of topical and systemic stress. Br J Cancer (1976) 0.82
Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Cancer Res (1992) 0.81
Carcinogen-induced mammary tumors from preneoplastic nodule outgrowths in BALB-c mice. Cancer Res (1970) 0.81
Effects of restraint stress on inoculated tumor growth and immune response in rats. Cancer Res (1985) 0.81
Male breast neoplasia in association with selective serotonin re-uptake inhibitor therapy: a report of three cases. Eur J Surg Oncol (2001) 0.81
Antidepressant therapy. A possible cause of atypical cutaneous lymphoid hyperplasia. Arch Dermatol (1995) 0.80
Molecular mechanisms of bidirectional communication between the immune and neuroendocrine systems. Int J Neurosci (1990) 0.80
Effects of alprazolam on the development of MTV-induced mammary tumors in female mice under stress. Cancer Lett (1992) 0.80
Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor. Psychol Bull (1985) 0.80
Modulation of immune cell function following fluoxetine administration in rats. Pharmacol Biochem Behav (1998) 0.80
Effects of nefazodone on the immune system of mice. Eur Neuropsychopharmacol (2000) 0.80
Effects of benzodiazepines on the immune system. Acta Neurol (Napoli) (1991) 0.78
Enhancing effect of thoracotomy on tumor growth in rats. Gan (1978) 0.78
Stress-induced suppression of natural killer cell cytotoxicity in the rat: a naltrexone-insensitive paradigm. Behav Neurosci (1990) 0.77
Specific response of mouse tumor-feeding arterioles to stimulation by 5-HT1 agonists. Int J Radiat Oncol Biol Phys (1997) 0.77
Immunoenhancing effects of alprazolam in mice. Life Sci (1990) 0.77
Effects of alprazolam on cellular immune response to surgical stress in mice. Cancer Lett (1993) 0.77
Delayed developmental neuro- and immunotoxicity of benzodiazepines. Arch Toxicol Suppl (1995) 0.77
Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat. Gen Pharmacol (1997) 0.76
Possible immunological effects of psychotropic medication. Psychosomatics (1993) 0.76
Human psychoneuroimmunology today. J Clin Lab Anal (1990) 0.75
Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment. J Clin Psychopharmacol (1994) 0.75
Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity. Brain Res (1993) 0.75
Concern over Prozac-induced tumor growth may dwindle following FDA study. J Natl Cancer Inst (1995) 0.75
Do antidepressants promote tumor growth? Am J Psychiatry (1996) 0.75
Candida albicans osteomyelitis: case report and literature review. Int J Infect Dis (2004) 1.24
Myxoma of the aortic valve. Interact Cardiovasc Thorac Surg (2012) 1.14
Evolution of the thymus size in response to physiological and random events throughout life. Microsc Res Tech (2003) 1.00
Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. J Psychiatr Res (2010) 0.96
Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. Biol Psychiatry (2011) 0.88
Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res (2011) 0.87
Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats. Hum Exp Toxicol (2007) 0.87
No evidence that major mtDNA European haplogroups confer risk to schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2012) 0.85
Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophr Res (2006) 0.83
LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs. Clin Biochem (2008) 0.83
Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes. Psychiatry Res (2010) 0.80
Effects of resveratrol on expression of vascular endothelial growth factor in human gingival fibroblasts stimulated by periodontal pathogens. Acta Odontol Scand (2010) 0.80
Effects of nefazodone on voluntary ethanol consumption induced by isolation stress in young and aged rats. Pharmacol Biochem Behav (2002) 0.80
Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase. J Cell Biochem (2012) 0.80
Antiradical activity, phenolics profile, and hydroxymethylfurfural in espresso coffee: influence of technological factors. J Agric Food Chem (2010) 0.79
Music, immunity and cancer. Life Sci (2002) 0.79
Administration of the 5-hydroxytryptamine(1A) receptor antagonist WAY100635 suppresses acute experimental allergic encephalomyelitis in Lewis rats. Neurosci Lett (2003) 0.79
Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett (2005) 0.79
Effects of fluoxetine on the activity of phagocytosis in stressed mice. Life Sci (2002) 0.78
Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs. Ann Hum Genet (2013) 0.78
Cloning and heterologous overexpression of three gap genes encoding different glyceraldehyde-3-phosphate dehydrogenases from the plant pathogenic bacterium Pseudomonas syringae pv. tomato strain DC3000. Protein Expr Purif (2013) 0.76
Effects of psychological stress and fluoxetine on development of oral candidiasis in rats. Clin Vaccine Immunol (2010) 0.76
Evaluation of three dosing models for the prediction of steady-state trough clozapine concentrations. Clin Biochem (2008) 0.75
Emotion regulation strategies in trauma-related disorders: pathways linking neurobiology and clinical manifestations. Rev Neurosci (2016) 0.75
Apical suction leads to severe ischemia of the ventricular apex. Eur J Cardiothorac Surg (2006) 0.75
Excitatory and inhibitory conversive experiences: neurobiological features involving positive and negative conversion symptoms. Rev Neurosci (2016) 0.75
[Multidisciplinary approach of Clostridium difficile infection]. Rev Chilena Infectol (2013) 0.75